This basic model was subsequently followed by variant versions when additional genetic modifications found or suspected in human SCLC tumors were introduced: inactivation of Rbl2, another member or the Rb family, resulted in accelerated SCLC tumor development [69]. The gene discussed is RB1; the disease is small cell lung carcinoma.